Evome Medical Technologies, Inc.: operating_income
| Value | {"unit": "CAD", "value": -607946, "concept": "us-gaap:OperatingIncomeLoss"} |
|---|---|
| Period | 2021-03-01 – 2022-02-28 |
| Status | current |
| Entity | Evome Medical Technologies, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:38:08.529855+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/3aab3406-0df7-4ba0-a9b8-5b7b0ba2630c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001062993-23-008238Retrieved: 2026-08-19T16:38:08.529855+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001617765/operating-income/2022-02-28 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/3aab3406-0df7-4ba0-a9b8-5b7b0ba2630c
History
- supersedes {"unit": "CAD", "value": 233820, "concept": "us-gaap:OperatingIncomeLoss"} (evidence 0001062993-22-013882)